NCT06327061 Social Network Overdose Prevention and Education Intervention
| NCT ID | NCT06327061 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins Bloomberg School of Public Health |
| Condition | Drug Overdose |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2028-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2024-06-01 with a primary completion date of 2028-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to test a social intervention focused on overdose prevention and care. In the investigators prior work, the investigators have shown that people who use opioids (PWUO) can be effective peer educators (PEs).
Eligibility Criteria
Inclusion Criteria: * self-reported illicit opioid use at least 2 times in the past two weeks; * age 18 and older; * living in the Baltimore metropolitan region; * willing to engage in peer education; and * having and willing to recruit at least one non-using network member. Exclusion Criteria: Participants without the cognitive ability to provide informed consent and have the physical ability to participate in in-person intervention sessions.
Contact & Investigator
Carl Latkin, PhD
PRINCIPAL INVESTIGATOR
Johns Hopkins University
Frequently Asked Questions
Who can join the NCT06327061 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Drug Overdose. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06327061 currently recruiting?
Yes, NCT06327061 is actively recruiting participants. Contact the research team at carl.latkin@jhu.edu for enrollment information.
Where is the NCT06327061 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT06327061 clinical trial?
NCT06327061 is sponsored by Johns Hopkins Bloomberg School of Public Health. The principal investigator is Carl Latkin, PhD at Johns Hopkins University. The trial plans to enroll 600 participants.